Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer

被引:4
|
作者
Kinuya, Seigo
Yokoyama, Kunihiko
Michigisuh, Takatoshi
Tonami, Norihisa
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Biotracer Med, Kanazawa, Ishikawa 9208640, Japan
[2] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa, Japan
关键词
I-131; thyroid cancer; neck edema; respiratory distress; complication;
D O I
10.1007/BF02987260
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Respiratory distress accompanied by stridor is an uncommon complication of I-131 radioiodine therapy for differentiated thyroid cancer that occurs within 48 hours of treatment. This report presents three Oases with papillary thyroid carcinoma in which I-131 therapy caused this acute complication. One of them had no apparent risk for this complication such as the existence of remnant thyroid tissue or laryngeal problems before the treatment. These cases remind physicians that I-131 therapy is not a simple, riskless procedure.
引用
收藏
页码:499 / 502
页数:4
相关论文
共 50 条
  • [1] Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
    Seigo Kinuya
    Kunihiko Yokoyama
    Takatoshi Michigishi
    Norihisa Tonami
    [J]. Annals of Nuclear Medicine, 2006, 20
  • [3] Retrospective Analysis of Radioiodine Therapy for Differentiated Thyroid Cancer Patients
    Gunes, B.
    Demir, M.
    Kanmaz, B.
    Kabasakal, L.
    Sayman, H.
    Onsel, C.
    Uslu, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S446 - S446
  • [4] Radioiodine Therapy in Patients with Stage I Differentiated Thyroid Cancer
    Jonklaas, Jacqueline
    Cooper, David S.
    Ain, Kenneth B.
    Bigos, Thomas
    Brierley, James D.
    Haugen, Bryan R.
    Ladenson, Paul W.
    Magner, James
    Ross, Douglas S.
    Skarulis, Monica C.
    Steward, David L.
    Maxon, Harry R.
    Sherman, Steven I.
    [J]. THYROID, 2010, 20 (12) : 1423 - 1424
  • [5] Guidelines for radioiodine therapy of differentiated thyroid cancer
    M. Luster
    S. E. Clarke
    M. Dietlein
    M. Lassmann
    P. Lind
    W. J. G. Oyen
    J. Tennvall
    E. Bombardieri
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
  • [6] Guidelines for radioiodine therapy of differentiated thyroid cancer
    Luster, M.
    Clarke, S. E.
    Dietlein, M.
    Lassmann, M.
    Lind, P.
    Oyen, W. J. G.
    Tennvall, J.
    Bombardieri, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1941 - 1959
  • [7] Guidelines for radioiodine therapy in differentiated thyroid cancer
    Dietlein, M
    Dressler, J
    Farahati, J
    Leisner, B
    Moser, E
    Reiners, C
    Schicha, H
    Schober, O
    [J]. NUKLEARMEDIZIN, 1999, 38 (6A) : 221 - 222
  • [8] Conventional Radioiodine Therapy for Differentiated Thyroid Cancer
    Ylli, Donna
    Van Nostrand, Douglas
    Wartofsky, Leonard
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 181 - +
  • [9] The efficacy of low dose radioiodine therapy in differentiated thyroid cancer patients
    Yoon, S.
    Choi, B.
    Hong, S.
    Joh, C.
    Yoon, J.
    Lee, K.
    So, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S374 - S374
  • [10] Radioiodine therapy in the different stages of differentiated thyroid cancer
    Valerio, Laura
    Maino, Fabio
    Castagna, Maria Grazia
    Pacini, Furio
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (01)